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Background: Disclosing HIV serostatus is important for HIV prevention and maintenance of health for people living
with HIV their spouses and the community, it plays a role in the social relation which is critical in reducing HIV
transmission. The process may have positive and negative effects to the HIV infected people who disclose their
status. The present study was undertaken to describe HIV serostatus disclosure among HIV infected people
attending care and treatment clinic at Sekou-Toure hospital in Mwanza, Tanzania.
Methods: A cross-sectional study was carried out on 270 HIV infected adults attending Care and Treatment Clinic
(CTC) at Sekou-Toure hospital between September and October, 2010. A Swahili questionnaire was used to obtain
demographic and HIV disclosure information.
Results: Hundred and ninety five (72.5%) of all recruited participants were females, 88.1% (238/270) were aged
above 30 years and 44.1% (119/270) were married. The prevalence of serostatus disclosure was 93.3% (252/270)
with participants aged above 30 years having significantly higher proportion of serostatus disclosure compared to
those aged below 30 years (94.5% vs. 84.4%, p < 0.05). Among the participants who disclosed their status, 69.3%
reported closeness to the disclosed person as the reason for disclosure while 25.8% (65/252) disclosed because they
needed help. Two hundred (79.4%) reported to have received emotional support following disclosure while 25.8%
and 29.7% received financial support and freedom to use their anti-retroviral drugs around the person they
disclosed their status respectively. Thirty four participants reported to have been discriminated following disclosure
and 12 participants reported to have been divorced.
Conclusions: Rate of disclosure of HIV serostatus was noted to be high in this study. Delayed disclosure was also
noted in small proportion of participants. Negative outcomes following disclosure of serostatus were reported by
participants. Efforts need to be increased to promote disclosure of HIV serostatus in Tanzania through health
education and awareness for both HIV infected individuals and the community.Background
HIV/AIDS is still a major burden to the health system in
Tanzania as it is for other Sub-Sahara African countries.
The current estimate for HIV prevalence in Tanzania is
5.6% [1] it is about 1.3% lower than previously reported
rate [2]. It is estimated that 1.4 million people are living
with HIV in Tanzania [1] with females more affected as
compared to their male counterparts.
Prevention of new infection is the cornerstone in the
fight against HIV/AIDS. Disclosure of HIV status is an
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reproduction in any medium, provided the orcounselling (VCT) services. Maman reported 64.5% dis-
closure among HIV positive women attending VCT clinic
in Dar es Salaam-Tanzania [3]. In another study conducted
among HIV infected pregnant women in Morogoro,
Tanzania 41% had disclosed to their partners [4].
Studies conducted in Tanzania have reported age, level
of education and financial independence particularly for
women to be important factors in predicting HIV seros-
tatus disclosure. Kiula et al. in a study conducted in
Morogoro, Tanzania reported that HIV-positive women
with high level of education, younger and financially in-
dependent to be more likely to disclose their serostatus
[4]. Lugalla et al. reported women to be less likely to re-
veal their status to their spouses as compared to men in
a study which was conducted among clients attendingLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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et al. among people living with HIV attending care and
treatment clinic in Kisarawe, Tanzania disclosure was
noted to be similar between males (97.0%) and females
(98.5%), however male participants (74.2%) were noted
to disclose more to their spouses than female participants
(47.7%) [6].
HIV status disclosure has been reported to benefit
PLWHA in several ways including psychological, emo-
tional and material support from family and other com-
munity members and freedom to use ARV medications
[7-9]. HIV transmission occurs between partners includ-
ing spouses, therefore disclosure of status will provide
timely access to care and treatment services in case the
partner/spouse is also affected [10]. Uninfected partners
in discordant couples will benefit through taking appropri-
ate actions including safer sex practices to prevent acquisi-
tion of HIV. Negative outcomes have been attributed to
disclosure; these may include rejection, assault, separation,
divorce, stigma and discrimination [3,8]. This study was
conducted to examine reasons and effects of HIV seros-
tatus disclosure among PLWHA attending CTC clinic
at Sekou-Toure Hospital in Mwanza, Tanzania.
Methods
Study design and population
A hospital based cross-sectional study was conducted
between September and October, 2010 at Sekou- Toure
hospital in Mwanza, Tanzania. A total of 270 (89%)
adults living with HIV/AIDS aged 18 years and above
who were attending care and treatment clinic for more
than six months were recruited. The sample size was
determined using proportional formula for calculating
sample size; a prevalence of disclosure of 23% from
Zimbabwe [11] was utilized for sample size calculation
aiming at a power of 80% with a response rate of 90%.
Study area
Mwanza is the second largest city in Tanzania located on
the Southern shore of Lake Victoria with an estimated
population of 2.5 million inhabitants. Sekou-Toure is a re-
gional hospital serving as a referral hospital to five district
hospitals. The care and treatment clinic is specific clinic
offering services exclusively to HIV infected patients. The
clinic is operating daily on working days and it is manned
with two clinicians and four nurses. The average patients’
attendance is 40 patients in each clinic day.
Data collection
Data were collected using pre-tested interviewer-
administered Swahili questionnaires which were de-
veloped for this study. Participants were recruited
consecutively at the CTC clinic during their monthly
visits. All consented participants were interviewed inthe clinic. Participants were requested to participate
voluntarily and no compensation was provided for this
study. The information sought included demographic
variables which were age, sex, marital status, level of
education and occupation. Other information sought
from participants included HIV disclosure status, time
of disclosure, outcomes following disclosure and rea-
sons for and for not disclosing. Single multiple response
questions were asked to determine disclosure status:
“Have you ever told anyone about your HIV status?”
The person disclosed to was determined by asking: “who
was the first person you disclosed your HIV status to?” If
the individual had not disclosed his/her HIV status the
reasons for not disclosing were explored. Immediate reac-
tion of person disclosed to were probed and the perceived
benefits and adverse outcomes were explored from partici-
pants. Reasons for not disclosing and outcomes following
disclosure were expressed as frequencies according to par-
ticipants’ responses, more than one response was provided
by some participants. Participants were asked if they felt
stigmatized and discriminated following disclosure.
Ethical considerations
This study was approved by the MUHAS ethical review
committee. Permission to carry out the study was sought
from district health authorities and the hospital manage-
ment. Participants gave verbal informed consents prior
to recruitment into this study.
Data analysis
Epi Info version 6 statistical package was used for data
entering, cleaning and analysis. Chi square and Fischer’s
exact test were used to determine association between
categorical variables. A probability (p) value of ≤0.05 was
considered statistically significant.
Results
A total of 270 (89%) participants were recruited during
the study duration. Of the participants 72.2% (195/270)
were females and 88.1% (238/270) were aged above 30
years, the mean age of study participants was 39.3 ±
8.5 years. One hundred and nineteen (44.1%) were mar-
ried, 73.7% (199/270) had primary school education and
73.0% (197/270) were employed. Two hundred and fifty
two participants (93.3%) had disclosed their HIV sero-
status. As shown in Table 1, male and female had similar
disclosure status 93.3%. The difference between partic-
ipants who disclosed and did not were not significant
except for age category whereby the proportion of partici-
pants who had disclosed their status was higher among
participants aged above 30 years as compared to those
aged below 30 years (94.5% vs. 84.4%, p = 0.0304) as
shown in Table 1. Fifty percent of participants who dis-
closed reported to have done it to their family member/
Table 1 Prevalence of disclosure status by demographic characteristics among PLWHA (N = 270)
Disclosure status
Socio-demographic characteristic Category N Yes n (%) No n (%) P-value
Sex Females 195 182 (93.3) 13 (6.7) 0.9777
Males 75 70 (93.3) 5 (6.7)
Age < 30 years 32 27 (84.4) 5 (15.6) 0.0304
> 30 years 238 225 (94.5) 13 (5.5)
Education Informal 43 40 (93.0) 3 (7.0) 0.6679
Primary 199 186 (93.5) 13 (6.5)
Secondary 26 24 (92.3) 2 (7.7)
College/university 2 2 (100) 0 (0)
Marital status Single 9 8 (88.9) 1 (11.1) 0.5845
Married 119 111 (93.3) 8 (6.7)
Cohabiting 32 28 (87.5) 4 (12.5)
Widow(er) 63 60 (95.2) 3 (4.8)
Divorced 47 45 (95.7) 2 (4.3)
Occupation Employed 197 183 (92.9) 14 (7.1) 0.6679
Self-employed 33 32 (97.0) 1 (3.0)
No specific job 40 37 (92.5) 3 (7.5)
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19% to their parents/guardians as described in Table 2.
Majority of participants 169/252 reported to have dis-
closed their status because of close relationship to the
person they told. Other reasons for disclosing included
need for help (65/252) and advice from VCT care pro-
viders (28/252). Two hundred and fourteen participants
(84.9%) disclosed their status within one month of diagno-
sis, 14/252 (5.6%) between one to six months and 24/252
(9.5%) disclosed after six months of knowing their HIV
status. Reasons given by 18 participants who did not dis-
close their status included fear of being abandoned byTable 2 Distribution of recipients of disclosure and their
initial reactions
Variable Number (%)
To whom did you disclose your HIV status first? (N = 252)
Spouse 64 (25.4%)
Parent/guardian 48 (19.0%)
Close relative 128 (50.8%)
Close friend 10 (4.0%)
Others 2 (0.8%)
What was the reaction of the first person to whom
you disclosed your status?(n = 252)†
She/he was shocked 41 (16.3%)
She/he cried 7 (2.8%)
She/he was understanding 137 (54.4%)
She/he laughed at me 1 (0.4%)
† 66 participants did not report any reaction.family members reported by six participants, fear of di-
vorce and abandonment by family members (2/18), fear of
divorce was reported by only one participant (1/18). Five
participants reported that they did not see the importance
of disclosing while four did not give any reason.
Emotional support following disclosure was reported by
124 (49.2%) while financial support following disclosure
was reported by 11.9% (30/252) of participants. Some par-
ticipants (13.1%) reported that they received emotional
support, financial support and were able to use their
ARV freely following disclosure as opposed to the habit
of hiding their medications and using them secretly
which was the case before disclosure,. The negative effects
of disclosure reported in this study included stigma and
discrimination which was reported by 13.5% (34/252) and
divorce which resulted from disclosure as reported by 10%
(12/111) of married participants (Table 3).
Discussion
This study was conducted to determine reasons and
effects of HIV serostatus disclosure among PLWHA in
Mwanza, Tanzania. Most people living with HIV/AIDS
(93.3%) reported to have disclosed their serostatus. Find-
ings from this study are similar to reports by Deribe et al.
(94.5%) and Seid et al. (93.1%) from studies conducted
among HIV infected men and women using clinical ser-
vices in Ethiopia [12,13]. The rate of disclosure was similar
between males and females in this study, contrary to re-
ports by Anglewicza et al. and Simbayi et al. in studies
conducted in Malawi and South Africa respectively, which
noted higher rates of disclosure to sexual partners among
Table 3 HIV status disclosure outcome
Experienced outcomes n %
Positive outcomes (n = 252)
Emotional support 124 49.2%
Freedom to use ART 12 4.8%
Financial support 30 11.9%
Freedom to use ART and emotional support 28 11.1%
Freedom to use ART and financial support 2 0.8%




Stigma and discrimination (n = 252) 34 13.5%
Divorce (n = 111)† 12 10.8%
†n is the total number of married participants who disclosed their serostatus.
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et al. reported higher proportion of male participants to
have disclosed to their sexual partners in a study conducted
among CTC clients in Kisarawe district in Tanzania [6].
Participants aged above 30 years had significantly higher
prevalence of serostatus disclosure as compared to those
aged below 30 years. Similar findings were reported by
Maman et al. and Zou et al. both of which found older age
to be a predictor of HIV serostatus disclosure, both studies
were carried out in Tanzania [7,16]. Zou et al. reported
older Christians to be more willing to disclose their seros-
tatus if they were found to be HIV positive. Contrary to
these findings Kiula et al. reported younger pregnant
women to be more likely to disclose their serostatus in a
study conducted in Morogoro, Tanzania [4]. The likeli-
hood of disclosure among older participants in our study
may be attributed to their maturity and sense of responsi-
bility; however there seem to be a need to explore in depth
on the influence of age on HIV serostatus disclosure in
Tanzania.
Disclosure to close relative was reported by half of the
participants who told their status and only 25% reported
spouse as the first person they told their status. This is
contrary to report by Lugalla et al. who reported 42% of
respondents to have disclosed to their spouses in a study
which was conducted among CTC clients who were re-
cruited after completion of testing and counselling in
Tanzania [5]. It is possible that married participants in our
study disclosed their status to their spouses subsequently;
however any delays could have serious implication in the
transmission of HIV particularly for discordant couples in
events where protective measures like condoms would
have not been used during sexual intercourse.
It is encouraging that majority (84.9%) of participants
disclosed within six months of knowing their diagnosis.
However 15.1% of participants had delayed disclosure
similar to 14.2% reported by Deribe et al. in a studyconducted among HIV infected men and women using
clinical services in Ethiopia [12]. Lugalla et al. reported
lower rates of disclosure within the first month of diagno-
sis in a study conducted among VCT clients in Tanzania
in which more than a quarter of the respondents reported
disclosure within one month of diagnosis [5]. Delayed
disclosure increases the risk of transmission of HIV in-
fections especially when condoms are not used during
sexual contact and may downplay the benefits of HIV
status disclosure, this may be particularly the case im-
mediately following the receipt of HIV results.
Serostatus disclosure plays an important role in improv-
ing quality of life for PLWHA, benefits of serostatus dis-
closure reported in this study included freedom to use
ARV drugs, financial and moral support, similar findings
have been reported in literature, Stirratt et al. in a study
which was conducted in New York among HIV seroposi-
tive patients reported poor adherence to ART among par-
ticipants who had not disclosed their status [17]. Norman
et al. reported financial and emotional support following
disclosure from family and community members in a
study conducted among PMTCT clients and health care
providers in South Africa [7]. Advice and counselling from
health care providers were reported to have led to HIV
serostatus disclosure among our participants, this finding
demonstrate the important role played by health care pro-
viders in facilitating HIV status disclosure. Role of health
care providers in facilitating disclosure have been previ-
ously reported, Kadowa et al. and Mucheto et al. reported
counselling and advice from health care providers to
predict disclosure in studies conducted among PLWHA
in Uganda and Zimbabwe respectively [7,18-21].
Negative outcomes following HIV serostatus disclosure
may result in individuals opting to withhold their status
to family, friends and community. Stigma, discrimination
and divorce following HIV sero-status disclosure was re-
ported by few participants in this study. This signifies the
importance of increasing awareness in our communities
to alleviate stigma attached to HIV infection. Separation
and divorce have been documented as important factor
hindering disclosure, Mucheto et al. reported women who
believed disclosure would cause divorce were to be less
likely to disclose in a study conducted among HIV in-
fected women attending antenatal and postnatal clinic in
Zimbabwe [7,19,22]. Couple counselling may be a useful
strategy to mitigate spousal rejection and enhance serosta-
tus disclosure in our communities.Study limitations
This study was based on self-reporting which may have
over or underestimated the disclosure status. This was a
cross-sectional study therefore some aspects of disclosure
could not have been explored adequately. Findings of this
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as it was carried out in one health facility.
Conclusions
High rate of HIV disclosure noted in this study is encour-
aging, however it is important to consider the negative
outcomes following disclosure reported in this study. The
delay in disclosure and the small proportion of partici-
pants who had not disclosed sends an important message
to the players in the fights against HIV/AIDS to put em-
phasis on increasing awareness in the community on the
impact of stigma and discrimination. There is a need
therefore, to explore factors which are hindering success-
ful and timely disclosure of HIV serostatus in Tanzania.
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